These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8087793)

  • 61. Pharmaceutical reimbursement: an overview.
    Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S4-10. PubMed ID: 18192246
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Specialty practice costs may vary by payer type, study finds.
    Capitation Rates Data; 2003 Mar; 8(3):32-5. PubMed ID: 12661327
    [No Abstract]   [Full Text] [Related]  

  • 63. Vital practices need adequate reimbursement.
    Norris D
    Fam Pract Manag; 2004 Apr; 11(4):14. PubMed ID: 15101152
    [No Abstract]   [Full Text] [Related]  

  • 64. Do we need Medicare?
    Frey DR
    Fam Pract Manag; 2008 Mar; 15(3):12. PubMed ID: 18426022
    [No Abstract]   [Full Text] [Related]  

  • 65. Managed care companies and the practice of medicine.
    Goodman C; Newcomer L; Young R; Kanwit S; Agrawal G; Davenport-Ennis N; Monaco GA; Rose LJ
    Oncology (Williston Park); 2000 Nov; 14(11A):82-91. PubMed ID: 11195423
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preparing for a medicare fee cut.
    Moore KJ
    Fam Pract Manag; 2008 May; 15(5):19-21. PubMed ID: 18546802
    [No Abstract]   [Full Text] [Related]  

  • 67. Reimbursement and pharmacoeconomic perspectives in biotechnology.
    Bleecker GC
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S27-30. PubMed ID: 8362887
    [TBL] [Abstract][Full Text] [Related]  

  • 68. How to judge the cancer services benefit component of your health insurance plan.
    Mortenson LE
    Cancer; 1998 May; 82(10 Suppl):2061-7. PubMed ID: 9587108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Do we need Medicare?
    Kuzio DJ
    Fam Pract Manag; 2008 Mar; 15(3):12. PubMed ID: 18426021
    [No Abstract]   [Full Text] [Related]  

  • 70. How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
    Schleicher SM; Wood NM; Lee S; Feeley TW
    Oncology (Williston Park); 2016 May; 30(5):468-74. PubMed ID: 27188679
    [No Abstract]   [Full Text] [Related]  

  • 71. A Farewell to Falsity: Shifting Standards in Medicare Fraud Enforcement.
    Buck ID
    Seton Hall Law Rev; 2019; 49(1):1-51. PubMed ID: 30557921
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost considerations in the management of cancer in the older patient.
    McKoy JM; Fitzner KA; Edwards BJ; Alkhatib M; Tigue CC; Nonzee NJ; Bolden CR; Bennett CL
    Oncology (Williston Park); 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim. PubMed ID: 17722744
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Wrestling with the managed care octopus, Part 2. Stay up to date on patients' health benefits.
    Larkin H
    Med Econ; 1999 Apr; 76(8):93-4, 101-2, 105-6. PubMed ID: 10387834
    [No Abstract]   [Full Text] [Related]  

  • 74. Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value.
    Sorenson C; Drummond M; Burns LR
    Health Aff (Millwood); 2013 Apr; 32(4):788-96. PubMed ID: 23569060
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Luxury primary care.
    Lucak BK
    N Engl J Med; 2002 Aug; 347(8):618-20; author reply 618-20. PubMed ID: 12195596
    [No Abstract]   [Full Text] [Related]  

  • 76. Practice expense costs in pulmonary and critical care practices. Is providing patient care still economically feasible?
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1524-7. PubMed ID: 11401867
    [No Abstract]   [Full Text] [Related]  

  • 77. IOM issues its first report on Medicare's GPCIs-IMS' quest for GPCI equity continues.
    Freeman J
    Iowa Med; 2011; 101(3):12. PubMed ID: 21882513
    [No Abstract]   [Full Text] [Related]  

  • 78. Managed oncology care: the disease management model.
    Piro L; Doctor J
    Cancer; 1998 May; 82(10 Suppl):2068-75. PubMed ID: 9587109
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reimbursement of biotherapy: present status, future directions--perspectives of the hospital-based oncology nurse.
    McCabe MS
    Semin Oncol Nurs; 1992 Nov; 8(4 Suppl 1):3-7. PubMed ID: 1462056
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cost, coverage, and comparative effectiveness research: the critical issues for oncology.
    Pearson SD
    J Clin Oncol; 2012 Dec; 30(34):4275-81. PubMed ID: 23071229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.